Replies to post #413617 on Anavex Life Sciences Corp (AVXL)

[bas2020]

In investing, one needs to "read between the lines", as well as just listen to what the company has stated.

If a company has stated and shown that trial endpoints were ALL met, highlighted the Super Responders using Odds Ratios and are now verbalizing their move toward COMMERCIALIZATION, then it's very likely that another P3 trial won't be necessary.

We should see the details soon... if not by the ASM then certainly by AAIC.
Time to load up on cheap shares!